CTNI-50. A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB/OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: UPDATED RESULTS

Authors: Annie Hsieh, Elizabeth Gerstner, Solmaz Sahebjam, David Piccioni, Jian Campian, Jan Drappatz, Robert Aiken, Eudocia Lee, Mary Welch, Kevin Becker, Mickey Williams, Christopher Karlovich, Alona Muzikansky, Pierre Giglio, Percy Ivy, Tracy Batchelor, Isabel Arrillaga-Romany

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.315

Source: Full article


Abstract

Abstract